Shareholding disclosure

ADDEX THERAPEUTICS LTD

Declared position

32.558%

Threshold

Crossed upwards

Timeline

Published

03.11.2026

Transaction

28.10.2026

Voting rights breakdown

Voting rights acquired32.558%

Voting rights sold21.341%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

ZA01-000000000SUY5

Beneficial owner

ADDEX THERAPEUTICS LTD

Declared address

Addex Therapeutics, 1228 Plan-Les-Ouates, CH

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

ADDEX THERAPEUTICS LTD

Addex Therapeutics Ltd03.11.2026ZA01-000000000SUY5

Disclosure summary

ADDEX THERAPEUTICS LTD disclosed a holding in Addex Therapeutics Ltd on the acquisition side, published by SIX Exchange Regulation on 03.11.2026, at 32.558% of voting rights. Notice category: Single shareholder.

Disclosed position

32.558%

Voting rights acquired

Voting rights acquired32.558%

Voting rights sold21.341%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

ADDEX THERAPEUTICS LTD disclosed a holding in Addex Therapeutics Ltd, published on 03.11.2026.

Publication date03.11.2026

Transaction date28.10.2026

Issuing companyAddex Therapeutics Ltd

Beneficial ownerADDEX THERAPEUTICS LTD

Declared addressAddex Therapeutics, 1228 Plan-Les-Ouates, CH

CategorySingle shareholder

Voting rights acquired32.558%

Voting rights sold21.341%

Below threshold0%

ExchangeXSWX

Notification IDZA01-000000000SUY5

Commercial register

CHE-113.514.094

Registered

Zefix record

Source: SIX Exchange Regulation · Publication date: 03.11.2026

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open